Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?

On: April 12, 2026, 6:46 pm EDT

URL has been copied successfully!

Share this story:

Previous Post:Analysts Bullish on CytomX Therapeutics (CTMX) As CTMX Prices $250 Million Offering

Next Post:Repay Holdings (RPAY) Scales Up in Bill Payments and Customer Interactions; Analysts See 170%+ Upside